Literature DB >> 20492471

Zn²(+) -containing protein S inhibits extrinsic factor X-activating complex independently of tissue factor pathway inhibitor.

N Fernandes1, L O Mosnier, L Tonnu, M J Heeb.   

Abstract

BACKGROUND: Protein S (PS) has direct anticoagulant activity, independently of activated protein C (APC). The mechanisms underlying this activity remain unclear, because PS preparations differ in activity, giving rise to conflicting results. Some purification procedures result in loss of intramolecular Zn²(+) , which is essential for inhibition of prothrombinase.
OBJECTIVE: To investigate the inhibition of extrinsic factor (F)Xase by Zn²(+) -containing PS.
METHODS: Purified component extrinsic FXase assays were used to determine FXa generation in the presence and absence of PS and/or tissue factor pathway inhibitor (TFPI). Binding assays, immunoblots and thrombin generation assays in plasma supported the FXase data.
RESULTS: Zn²(+) -containing PS potently inhibited extrinsic FXase in the presence of saturating phospholipids, independently of TFPI, whereas inhibition of extrinsic FXase by Zn²(+) -deficient PS required TFPI. Immunoblots for FXa and functional assays showed that Zn²(+) -containing PS inhibited primarily the quantity of FXa formed by tissue factor (TF)-FVIIa, rather than FXa amidolytic activity. Zn²(+) -containing PS, but not Zn²(+) -deficient PS, bound to TF with high affinity (K(dapp) = 41 nm) and targeted TF function. Binding of PS to FVIIa was negligible, whereas PS showed appreciable binding to FX. Increasing FX concentrations 10-fold reduced PS inhibition five-fold, suggesting that PS inhibition of FXase is FX-dependent. PS also exhibited TFPI-independent and APC-independent anticoagulant activity during TF-initiated thrombin generation in plasma.
CONCLUSIONS: PS that retains native Zn²(+) also retains anticoagulant functions independently of APC and TFPI. Inhibition of extrinsic FXase by PS at saturating levels of phospholipids depends on PS retention of intramolecular Zn²(+) , interaction with FX, and, particularly, interaction with TF.
© 2010 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20492471      PMCID: PMC2955986          DOI: 10.1111/j.1538-7836.2010.03919.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  18 in total

1.  Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X.

Authors:  F Doñate; C R Kelly; W Ruf; T S Edgington
Journal:  Biochemistry       Date:  2000-09-19       Impact factor: 3.162

2.  Neonatal purpura fulminans associated with homozygous protein S deficiency.

Authors:  C Mahasandana; V Suvatte; R A Marlar; M J Manco-Johnson; L J Jacobson; W E Hathaway
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

3.  Inactivation of factor VIII by activated protein C and protein S.

Authors:  F J Walker; S I Chavin; P J Fay
Journal:  Arch Biochem Biophys       Date:  1987-01       Impact factor: 4.013

4.  A procedure for isolation of human protein C and protein S as by-products of the purification of factors VII, IX, X and prothrombin.

Authors:  S P Bajaj; S I Rapaport; S L Maki; S F Brown
Journal:  Prep Biochem       Date:  1983

5.  Gamma-carboxylated isoforms of recombinant human protein S with different biologic properties.

Authors:  B W Grinnell; J D Walls; C Marks; A L Glasebrook; D T Berg; S B Yan; N U Bang
Journal:  Blood       Date:  1990-12-15       Impact factor: 22.113

6.  Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma.

Authors:  E Castoldi; P Simioni; D Tormene; J Rosing; T M Hackeng
Journal:  J Thromb Haemost       Date:  2009-11-30       Impact factor: 5.824

7.  Plasma protein S deficiency in familial thrombotic disease.

Authors:  H P Schwarz; M Fischer; P Hopmeier; M A Batard; J H Griffin
Journal:  Blood       Date:  1984-12       Impact factor: 22.113

8.  Protein S binds to and inhibits factor Xa.

Authors:  M J Heeb; J Rosing; H M Bakker; J A Fernandez; G Tans; J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

9.  Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C.

Authors:  M J Heeb; R M Mesters; G Tans; J Rosing; J H Griffin
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

10.  Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa.

Authors:  T M Hackeng; C van 't Veer; J C Meijers; B N Bouma
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

View more
  7 in total

1.  Platelet protein S directly inhibits procoagulant activity on platelets and microparticles.

Authors:  Fabian Stavenuiter; Nicole F Davis; Erning Duan; Andrew J Gale; Mary J Heeb
Journal:  Thromb Haemost       Date:  2012-12-13       Impact factor: 5.249

2.  Phosphorylation of protein S by platelet kinases enhances its activated protein C cofactor activity.

Authors:  Fabian Stavenuiter; Andrew J Gale; Mary J Heeb
Journal:  FASEB J       Date:  2013-04-11       Impact factor: 5.191

3.  Antithrombotic activity of protein S infused without activated protein C in a baboon thrombosis model.

Authors:  M J Heeb; U Marzec; A Gruber; S R Hanson
Journal:  Thromb Haemost       Date:  2012-02-28       Impact factor: 5.249

Review 4.  Protein C anticoagulant and cytoprotective pathways.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

5.  Relationship between serum zinc level and sepsis-induced coagulopathy.

Authors:  Yuhei Irie; Kota Hoshino; Yasumasa Kawano; Mariko Mizunuma; Ryo Hokama; Shinichi Morimoto; Yoshito Izutani; Hiroyasu Ishikura
Journal:  Int J Hematol       Date:  2021-10-20       Impact factor: 2.490

6.  Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.

Authors:  Mary J Heeb; Rolf M Mesters; José A Fernández; Tilman M Hackeng; Ryon K Nakasone; John H Griffin
Journal:  Thromb Haemost       Date:  2013-05-23       Impact factor: 5.249

7.  Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice.

Authors:  Hai Po H Liang; Edward J Kerschen; Sreemanti Basu; Irene Hernandez; Mark Zogg; Shuang Jia; Martin J Hessner; Raffaella Toso; Alireza R Rezaie; José A Fernández; Rodney M Camire; Wolfram Ruf; John H Griffin; Hartmut Weiler
Journal:  Blood       Date:  2015-09-04       Impact factor: 22.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.